Investing
587 Articles
It has been no secret that the market for initial public offerings has been one of the biggest ghost towns…
If you can believe it, there is an initial public offering on deck this week. Bristol-Myers Squibb Co. (NYSE: BMY)…
We haven’t been covering Jim Cramer as much for many different reasons, but we still pay attention when he comes…
There may be some speculation that drug giant Pfizer Inc. (NYSE: PFE) is looking at expansion through acquisitions. The FT…
People who get to the end of 2008 and are still at work can be thankful. The unemployment rate will…
According to Reuters, the Fed may need to use a trillion dollars to halt the economy from moving into a…
There are few positive calls this morning from Wall Street analysts, but these are the ones we have caught this…
These are some of the top analyst upgrades we have seen this Friday morning: Abercrombie & Fitch (ANF) Raised to…
Analysts assume third quarter earnings for the companies in the S&P 500 will be bad. But, looking at the number…
Carl Icahn appears to have won a blue ribbon for ImClone Systems (NASDAQ: IMCL) shareholders. The biotech stock is trading…
ImClone Systems Inc. (NASDAQ: IMCL) is among the biotech bonanza merger candidates with one deal on the table and perhaps…
According to Reuters, Wilbur Ross say the bailout package does not address the core of problem which is mortgage payments.…
There is some very hopeful data out there this morning on cancer survival. Bristol-Myers Squibb Co. (NYSE: BMY) and Medarex,…
Bristol-Myers Squibb (NYSE: BMY) has sent a letter to Imclone Systems (NASDAQ: IMCL) in response to yesterday’s rejection of its…
ImClone Systems Inc. (NASDAQ: IMCL) is a biotech buyout bonanza stock that traders and investors have been watching closely. The…
Our top personal finance-related articles today. Your wallet will thank you later.